FDA Foreign Inspection Program "Will Be The Next Area Of Reform" - Mikulski
Executive Summary
FDA's foreign inspection program will be the next agency function to undergo reform, Sen. Mikulski (D-Md.) predicted in an address to PhRMA May 11.
You may also be interested in...
FDA Losing Ground On Foreign Manufacturing Inspections, House Panel Says
Congress is refocusing its interest on an FDA issue that it has looked at periodically for more than a decade: drug import safety and the agency's failure to modernize its foreign inspections program
FDA Losing Ground On Foreign Manufacturing Inspections, House Panel Says
Congress is refocusing its interest on an FDA issue that it has looked at periodically for more than a decade: drug import safety and the agency's failure to modernize its foreign inspections program
FDA IT Infrastructure Inadequate For Managing Foreign Inspections, GAO Says
FDA's ability to oversee drug importation is encumbered by an inaccurate and dysfunctional information technology infrastructure, the Government Accountability Office asserts